Ophthalmic manifestations of sickle cell disease

Research output: Contribution to journalReview article

Abstract

Sickle cell disease (SCD), the most common inherited blood disorder, is characterized by defective oxygen transport. Every part of the eye can be affected by microvascular occlusions from SCD; however, the major cause of vision loss is proliferative sickle cell retinopathy (PSR). Although individuals with the HbSS genotype of SCD manifest more systemic morbidity and those with the HbSC genotype have a milder clinical course, those with HbSC have an increased risk of developing PSR and resultant vision loss. Sickle cell retinopathy has a variable phenotype, even among individuals with the same genotype. Most patients with SCD maintain good vision because the associated retinopathy occurs in the retinal periphery, and any associated "sea fan" neovascularization has a high tendency to autoinfarct and regress. Vision loss from PSR is largely preventable via regular retinal examinations and treatment as indicated. Novel retinal imaging techniques such as wide-field fluorescein angiography, spectral domain optical coherence tomography, and optical coherence tomography angiography can identify evidence of retinal microvascular occlusions in most patients with SCD. Further study is necessary to discover which individuals are at highest risk for vision loss, which of these retinal imaging modalities is clinically important, and which systemic treatments may decrease risk of vision loss from sickle cell retinopathy.

Original languageEnglish (US)
Pages (from-to)542-548
Number of pages7
JournalSouthern Medical Journal
Volume109
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Eye Manifestations
Sickle Cell Anemia
Genotype
Optical Coherence Tomography
Fluorescein Angiography
Oceans and Seas
Angiography
Oxygen
Morbidity
Phenotype
Therapeutics

Keywords

  • Key Words hemoglobinopathies
  • ophthalmic manifestation of sickle cell disease
  • retinal imaging
  • sickle cell retinopathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ophthalmic manifestations of sickle cell disease. / Scott, Adrienne.

In: Southern Medical Journal, Vol. 109, No. 9, 01.09.2016, p. 542-548.

Research output: Contribution to journalReview article

@article{21f7afbb5dc645e991681619c7247c3b,
title = "Ophthalmic manifestations of sickle cell disease",
abstract = "Sickle cell disease (SCD), the most common inherited blood disorder, is characterized by defective oxygen transport. Every part of the eye can be affected by microvascular occlusions from SCD; however, the major cause of vision loss is proliferative sickle cell retinopathy (PSR). Although individuals with the HbSS genotype of SCD manifest more systemic morbidity and those with the HbSC genotype have a milder clinical course, those with HbSC have an increased risk of developing PSR and resultant vision loss. Sickle cell retinopathy has a variable phenotype, even among individuals with the same genotype. Most patients with SCD maintain good vision because the associated retinopathy occurs in the retinal periphery, and any associated {"}sea fan{"} neovascularization has a high tendency to autoinfarct and regress. Vision loss from PSR is largely preventable via regular retinal examinations and treatment as indicated. Novel retinal imaging techniques such as wide-field fluorescein angiography, spectral domain optical coherence tomography, and optical coherence tomography angiography can identify evidence of retinal microvascular occlusions in most patients with SCD. Further study is necessary to discover which individuals are at highest risk for vision loss, which of these retinal imaging modalities is clinically important, and which systemic treatments may decrease risk of vision loss from sickle cell retinopathy.",
keywords = "Key Words hemoglobinopathies, ophthalmic manifestation of sickle cell disease, retinal imaging, sickle cell retinopathy",
author = "Adrienne Scott",
year = "2016",
month = "9",
day = "1",
doi = "10.14423/SMJ.0000000000000525",
language = "English (US)",
volume = "109",
pages = "542--548",
journal = "Southern Medical Journal",
issn = "0038-4348",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Ophthalmic manifestations of sickle cell disease

AU - Scott, Adrienne

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Sickle cell disease (SCD), the most common inherited blood disorder, is characterized by defective oxygen transport. Every part of the eye can be affected by microvascular occlusions from SCD; however, the major cause of vision loss is proliferative sickle cell retinopathy (PSR). Although individuals with the HbSS genotype of SCD manifest more systemic morbidity and those with the HbSC genotype have a milder clinical course, those with HbSC have an increased risk of developing PSR and resultant vision loss. Sickle cell retinopathy has a variable phenotype, even among individuals with the same genotype. Most patients with SCD maintain good vision because the associated retinopathy occurs in the retinal periphery, and any associated "sea fan" neovascularization has a high tendency to autoinfarct and regress. Vision loss from PSR is largely preventable via regular retinal examinations and treatment as indicated. Novel retinal imaging techniques such as wide-field fluorescein angiography, spectral domain optical coherence tomography, and optical coherence tomography angiography can identify evidence of retinal microvascular occlusions in most patients with SCD. Further study is necessary to discover which individuals are at highest risk for vision loss, which of these retinal imaging modalities is clinically important, and which systemic treatments may decrease risk of vision loss from sickle cell retinopathy.

AB - Sickle cell disease (SCD), the most common inherited blood disorder, is characterized by defective oxygen transport. Every part of the eye can be affected by microvascular occlusions from SCD; however, the major cause of vision loss is proliferative sickle cell retinopathy (PSR). Although individuals with the HbSS genotype of SCD manifest more systemic morbidity and those with the HbSC genotype have a milder clinical course, those with HbSC have an increased risk of developing PSR and resultant vision loss. Sickle cell retinopathy has a variable phenotype, even among individuals with the same genotype. Most patients with SCD maintain good vision because the associated retinopathy occurs in the retinal periphery, and any associated "sea fan" neovascularization has a high tendency to autoinfarct and regress. Vision loss from PSR is largely preventable via regular retinal examinations and treatment as indicated. Novel retinal imaging techniques such as wide-field fluorescein angiography, spectral domain optical coherence tomography, and optical coherence tomography angiography can identify evidence of retinal microvascular occlusions in most patients with SCD. Further study is necessary to discover which individuals are at highest risk for vision loss, which of these retinal imaging modalities is clinically important, and which systemic treatments may decrease risk of vision loss from sickle cell retinopathy.

KW - Key Words hemoglobinopathies

KW - ophthalmic manifestation of sickle cell disease

KW - retinal imaging

KW - sickle cell retinopathy

UR - http://www.scopus.com/inward/record.url?scp=84985997750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985997750&partnerID=8YFLogxK

U2 - 10.14423/SMJ.0000000000000525

DO - 10.14423/SMJ.0000000000000525

M3 - Review article

C2 - 27598358

AN - SCOPUS:84985997750

VL - 109

SP - 542

EP - 548

JO - Southern Medical Journal

JF - Southern Medical Journal

SN - 0038-4348

IS - 9

ER -